For the full fiscal year 2023, net profit was ₹819.1 crore compared to ₹1,055.6 crore in fiscal year 22, while sales increased by 13% to ₹16,612.5 crore from ₹14,662.6 crore in the previous fiscal year.
The Company’s Board of Directors announced a final dividend of ₹9 per share (180%) of the par value of ₹5 per share for fiscal 2023. The Company has set August 19 as the cut-off date for determining shareholder eligibility. The dividend will be paid from September 9th. For the last 12 months, the company has declared a stock dividend of ₹17.75 per share while paying 27 dividends since its listing in 2000.
As of March 31, 2023, Apollo Hospitals had a total of 70 hospitals throughout the network with 9,957 operating beds (including 562 beds in all-alliance everyday), of which 14 were new hospitals with 2,384 operating beds.
Consolidated revenue for the healthcare services division increased 18% year-on-year to ₹2,194.6 crore, with existing hospitals and new hospitals growing 18% and 16%, respectively. The occupancy rate in established hospitals was 65%, in new hospitals 62%.
The Healthcare Diagnostics and Retail business generated revenue of ₹308.5 crore while EBITDA was ₹25.5 crore. The company suffered a loss of ₹23.4 crore in the fourth quarter of fiscal 23.
(DISCLAIMER: The views and opinions of investment professionals on the subject Fortuneindia.com are either their own or their organizations, but not necessarily those of Fortuneindia.com and his editorial team. Readers are advised to consult certified professionals before making any investment decisions.)
